Kunihiko Suzuki is doing genetic studies as part of his Activator (genetics), Mutant and Mutation and Gene investigations. He performs integrative Mutant and Gene research in his work. His work often combines Biochemistry and Neuroscience studies. Kunihiko Suzuki undertakes multidisciplinary investigations into Neuroscience and Biochemistry in his work. His research on Disease often connects related areas such as Gangliosidosis. While working in this field, he studies both Endocrinology and Internal medicine. Kunihiko Suzuki brings together Internal medicine and Endocrinology to produce work in his papers. He combines Pathology and Immunology in his research. Kunihiko Suzuki merges Immunology with Pathology in his study.
In his research, Kunihiko Suzuki undertakes multidisciplinary study on Biochemistry and Cell biology. He combines Cell biology and Biochemistry in his research. Kunihiko Suzuki undertakes interdisciplinary study in the fields of Gene and Enzyme through his research. With his scientific publications, his incorporates both Enzyme and Gene. His Disease study frequently links to adjacent areas such as Internal medicine. Internal medicine is frequently linked to Disease in his study. His Pathology study typically links adjacent topics like Krabbe disease. In his research, Kunihiko Suzuki undertakes multidisciplinary study on Krabbe disease and Leukodystrophy. His study on Leukodystrophy is mostly dedicated to connecting different topics, such as Pathology.
His work on Composite material expands to the thematically related Layer (electronics). His Composite material study frequently draws connections between adjacent fields such as Layer (electronics). He integrates many fields, such as Optoelectronics and Electrical engineering, in his works. He conducted interdisciplinary study in his works that combined Electrical engineering and Optoelectronics. His OLED research extends to the thematically linked field of Nanotechnology. His Nanotechnology research extends to the thematically linked field of OLED. He performs integrative Pathology and Immunology research in his work. Kunihiko Suzuki incorporates Immunology and Pathology in his studies. His study connects Internal medicine and Disease.
Internal medicine and Pathology are two areas of study in which Kunihiko Suzuki engages in interdisciplinary research. He performs multidisciplinary studies into Pathology and Internal medicine in his work. His research on Mechanism (biology) frequently links to adjacent areas such as Epistemology. His research links Mechanism (biology) with Epistemology. He conducted interdisciplinary study in his works that combined Phenol and Benzene. He integrates several fields in his works, including Benzene and Organic chemistry. In his articles, he combines various disciplines, including Organic chemistry and Reaction mechanism. He undertakes multidisciplinary investigations into Reaction mechanism and Catalysis in his work. Kunihiko Suzuki integrates many fields, such as Catalysis and Phenol, in his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability
Timothy Coetzee;Nobuya Fujita;Jeffrey Dupree;Riyi Shi.
Cell (1996)
The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation
Kunihiko Suzuki.
Journal of Neurochemistry (1965)
Globoid Cell Leucodystrophy (Krabbe's Disease): Deficiency of Galactocerebroside β-Galactosidase
Kunihiko Suzuki;Yoshiyuki Suzuki.
Proceedings of the National Academy of Sciences of the United States of America (1970)
THE PATTERN OF MAMMALIAN BRAIN GANGLIOSIDES—III
Kunihiko Suzuki.
Journal of Neurochemistry (1965)
Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status.
Kunihiko Suzuki.
Neurochemical Research (1998)
The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease).
Takuro Kobayashi;Tatsuhiro Yamanaka;Jean M. Jacobs;Fernanda Teixeira.
Brain Research (1980)
Chemical Pathology of GM1-Gangliosidosis (Generalized Gangliosidosis)
Kunihiko Suzuki;Kinuko Suzuki;Shigehiko Kamoshita.
Journal of Neuropathology and Experimental Neurology (1969)
Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
Hugo W. Moser;Ann B. Moser;Nariko Kawamura;Jerome Murphy.
Annals of Neurology (1980)
Targeted Disruption of the Mouse Sphingolipid Activator Protein Gene: A Complex Phenotype, Including Severe Leukodystrophy and Wide-Spread Storage of Multiple Sphingolipids
Nobuya Fujita;Kinuko Suzuki;Marie T. Vanier;Brian Popko.
Human Molecular Genetics (1996)
Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase.
Hong Hua Li;Wei-Hong Yu;Nora Rozengurt;Hui-Zhi Zhao.
Proceedings of the National Academy of Sciences of the United States of America (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of North Carolina at Chapel Hill
Grenoble Alpes University
Northwestern University
University of Bonn
Albert Einstein College of Medicine
University of California, San Diego
University of California, Los Angeles
Virginia Commonwealth University
University of North Carolina at Chapel Hill
St. Jude Children's Research Hospital
Stanford University
Seoul National University
Cornell University
Max Planck Society
Old Dominion University
Federal University of Rio Grande do Norte
Nova Southeastern University
Institució Catalana de Recerca i Estudis Avançats
National Autonomous University of Mexico
University of Padua
University of Liverpool
National Institutes of Health
McMaster University
British Geological Survey
National Institute of Allergy and Infectious Diseases
The University of Texas MD Anderson Cancer Center